Compare OKE & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OKE | A |
|---|---|---|
| Founded | 1906 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Laboratory Analytical Instruments |
| Sector | Utilities | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.8B | 41.0B |
| IPO Year | N/A | 1999 |
| Metric | OKE | A |
|---|---|---|
| Price | $75.15 | $142.61 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 14 |
| Target Price | $91.14 | ★ $162.29 |
| AVG Volume (30 Days) | ★ 4.4M | 2.1M |
| Earning Date | 10-28-2025 | 11-24-2025 |
| Dividend Yield | ★ 5.50% | 0.72% |
| EPS Growth | ★ 13.61 | 3.16 |
| EPS | ★ 5.43 | 4.57 |
| Revenue | ★ $31,564,000,000.00 | $6,948,000,000.00 |
| Revenue This Year | $51.00 | $7.76 |
| Revenue Next Year | $6.72 | $6.24 |
| P/E Ratio | ★ $13.81 | $31.17 |
| Revenue Growth | ★ 58.35 | 6.73 |
| 52 Week Low | $64.02 | $96.43 |
| 52 Week High | $111.02 | $160.27 |
| Indicator | OKE | A |
|---|---|---|
| Relative Strength Index (RSI) | 65.62 | 40.90 |
| Support Level | $69.50 | $144.22 |
| Resistance Level | $76.85 | $160.27 |
| Average True Range (ATR) | 1.33 | 4.41 |
| MACD | 0.64 | -1.16 |
| Stochastic Oscillator | 80.12 | 10.83 |
Oneok is a diversified midstream service provider specializing in natural gas gathering, processing, storage, and transportation and natural gas liquids transportation and fractionation. It also operates a refined product and crude oil segment connecting producers, refiners, and consumers. Operations are in the midcontinent, Permian, and Rocky Mountain regions.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.